{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.464.1003.110.12.1045","meta":{"source":"https://vsac.nlm.nih.gov/valueset/2.16.840.1.113883.3.464.1003.110.12.1045/expansion"},"url":"http://vsac.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.12.1045","version":"eCQM Update 2020-05-07","name":"InactivatedPolioVaccine(IPV)Administered","title":"Inactivated Polio Vaccine (IPV) Administered","status":"active","date":"2017-05-04","description":"(Clinical Focus: This value set contains concepts that represent procedures for inactivated polio vaccine (IPV) administration.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to related to Procedure, Performed.),(Inclusion Criteria: Includes only relevant concepts associated with all inactivated polio vaccine (IPV) administration codes. This is a grouping of CPT and SNOMED CT codes.),(Exclusion Criteria: No exclusions.)","compose":{"include":[{"system":"http://snomed.info/sct","version":"http://snomed.info/sct/731000124108/version/2019-09","concept":[{"code":"396456003","display":"Diphtheria, acellular pertussis, hepatitis B and inactivated polio vaccination (procedure)"},{"code":"412762002","display":"First diphtheria, tetanus, acellular pertussis and polio vaccination (procedure)"},{"code":"414001002","display":"Diphtheria tetanus and five component acellular pertussis, haemophilus influenzae type b, inactivated polio vaccination (procedure)"},{"code":"414259000","display":"First diphtheria tetanus and five component acellular pertussis, haemophilus influenzae type b, inactivated polio vaccination (procedure)"},{"code":"414619005","display":"Low dose diphtheria, tetanus and inactivated polio vaccination (procedure)"},{"code":"414620004","display":"Low dose diphtheria, tetanus, five component acellular pertussis and inactivated polio vaccination (procedure)"},{"code":"415507003","display":"Second diphtheria tetanus and five component acellular pertussis, haemophilus influenzae type b, inactivated polio vaccination (procedure)"},{"code":"415712004","display":"Third diphtheria tetanus and five component acellular pertussis, haemophilus influenzae type b, inactivated polio vaccination (procedure)"},{"code":"416144004","display":"Third low dose diphtheria, tetanus and inactivated polio vaccination (procedure)"},{"code":"416591003","display":"First low dose diphtheria, tetanus and inactivated polio vaccination (procedure)"},{"code":"417211006","display":"First booster low dose diphtheria, tetanus and inactivated polio vaccination (procedure)"},{"code":"417384007","display":"Second booster low dose diphtheria, tetanus and inactivated polio vaccination (procedure)"},{"code":"417615007","display":"Second low dose diphtheria, tetanus and inactivated polio vaccination (procedure)"}]},{"system":"http://www.ama-assn.org/go/cpt","version":"2020","concept":[{"code":"90698","display":"Diphtheria, tetanus toxoids, acellular pertussis vaccine, Haemophilus influenzae type b, and inactivated poliovirus vaccine, (DTaP-IPV/Hib), for intramuscular use"},{"code":"90713","display":"Poliovirus vaccine, inactivated (IPV), for subcutaneous or intramuscular use"},{"code":"90723","display":"Diphtheria, tetanus toxoids, acellular pertussis vaccine, hepatitis B, and inactivated poliovirus vaccine (DTaP-HepB-IPV), for intramuscular use"}]}]}}